Shows
Trying 2 LearnEpisode 17- Dr. Hanadie Yousef | Protein Mapping & The Future of Regenerative MedicineSend us a textWhat if we could map the healing signals our bodies already use—and turn them into targeted therapies?In this episode, Dr. Hanadie Yousef, co-founder and CEO of Juvena Therapeutics, walks us through how her team is using stem cell systems biology and protein mapping to develop a new class of regenerative medicines.We explore:How secreted proteins mapping helps identify potential therapeuticsWhat it takes to go from protein signals to actual therapyWhy this approach could unlock treatments that are safer and more directed to...
2025-09-1232 min
Biotech CEO SisterhoodHanadie Yousef leads Juvena Therapeutics, a company developing protein based therapeutics that are tissue restorative for muscle and metabolic diseasesShe describes the process of how the company's computing platform sorts through proteins that are secreted by stem cells and screens them for therapeutic potential. Plus, the lead clinical program for muscle conditions and also a partnership with Lilly in the obesity space.
2025-09-0511 min
The Regenerative Health Podcast from TheRHA.orgAnti Aging and Enhancing Longevity - 2025 BioTech Showcase Expert PanelWelcome to a special edition of The Regenerative Health Association Podcast, recorded live at the 2025 Biotech Showcase in San Francisco. This year's conference, a cornerstone event in the life sciences industry, brought together over 3,200 global biotech and health leaders to discuss cutting-edge innovations in healthcare.Our podcast features an exceptional panel on "Enhancing Longevity," moderated by Professor Gordon Lithgow from the prestigious Buck Institute. The panel includes:Hanadie Yousef, CEO of Juvena Therapeutics, a pioneer in developing protein-based therapeutics for age-related diseases.Markus Gstöttner, CEO of Clock.bio, whose company recently raised $5.3M to decode the genetic a...
2025-01-1535 min
Impact AIDiscovering Protein Drug Candidates with Hanadie Yousef from Juvena TherapeuticsHow can advancements in biotechnology and machine learning lead to revolutionary treatments for age-related diseases? In this episode, I speak with Hanadie Yousef, CEO and Co-Founder of Juvena Therapeutics, to discuss her work on protein-based therapeutics. Hanadie, a neurobiologist specializing in aging and tissue degeneration, has pioneered research at Juvena to identify regenerative proteins that can restore tissue function and combat chronic diseases.In our conversation, Hanadie details Juvena’s AI-driven platform that identifies, validates, and engineers protein candidates with therapeutic potential. We explore the power of machine learning models in drug discovery, the challenges of working wi...
2024-11-2519 min
Citeline PodcastsIn Conversation With 2024 In Vivo Rising Leader, Hanadie YousefIn this episode, In Vivo speaks to 2024 Rising Leader Hanadie Yousef, CEO of Juvena Therapeutics, about her journey, the secretome as a source of therapeutics, longevity medicine and alternatives to GLP-1 inhibitors for obesity.
2024-04-0930 min
Pharmaceutical ExecutiveEmerging Potential: Changing Lives One Story, One Therapeutic at a TimeThe 2023 Emerging Pharma Leaders share with Meg Rivers, managing editor of Pharmaceutical Executive, and the editorial team what makes a good leader, what has made them the proudest in their career, lessons they wish they had known when starting out, and more.
Congratulations to the 2023 Emerging Pharma Leaders: Natasha A. Hernday, chief business officer, Seagen; Simon Holland, vice president, women's health commercial lead, Organon; Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio; Frank Watanabe, president and CEO, Arcutis Biotherapeutics; and Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics.
SPONSOR: APEX Awards
https://www...
2023-05-2550 min
Community in ArabicDr. Hanadie Yousef - Co-founder of Juvena Therapeutics talks about science & entrepreneurshipDr. Hanadie Yousef is a Palestinian-American molecular and cell biologist and co-founder of Juvena Therapeutics, a biotech startup specializing in age-related diseases and their therapeutics. Topics covered in Episode:1- About Hanadie2- Hanadie's immigration journey.3- The vision and mission of Juvena Therapeutics4- Raising $50+ MM and the challenges of being an entrepreneur5- Future goals & projects Hosts: Anwar Jebran & Malek Abdulsamad.Website: https://communityinarabic.comFacebook: https://www.facebook.com/CommunityinA...Instagram: https://www.instagram.com/communityin...
2023-03-0453 min
Progress, Potential, and Possibilities Podcast / ShowDr. Hanadie Yousef, Ph.D. Co-Founder & CEO - Juvena Therapeutics - Secretome Derived TherapiesSend a textDr. Hanadie Yousef, Ph.D. is a Scientist, Co-Founder and CEO of Juvena Therapeutics, a regenerative medicine company developing protein therapeutics to promote tissue regeneration and increase healthspan, to prevent, reverse, and cure degenerative diseases. For over 17 years, Dr. Yousef elucidated mechanisms of aging and developed methods for tissue regeneration supported by multiple awards, fellowships and grants. Her discoveries were published in top publications that include Nature Medicine and led to several issued patents which laid the foundation of Juvena Therapeutics’ venture-backed, drug discovery and pre-clinical development platform. Dr. Yousef earned a BS in Ch...
2021-08-2743 min
Translating AgingThe Cures Within Us (Hanadie Yousef — Juvena Therapeutics)Dr. Hanadie Yousef is a scientist, aging biology expert and the co-founder and CEO of Juvena Therapeutics, a Palo Alto-based biopharma startup developing protein-based therapeutics to promote tissue regeneration and increase healthspan to prevent, reverse, and cure degenerative diseases. Dr. Yousef joins host Dr. Chris Patil to discuss Juvena’s premise, their use of a machine learning platform to identify proteins that have therapeutic potential, and what most excites her about turning signaling proteins into therapeutics. She answers questions about handling potential challenges within Juvena’s approach, their strategy for bringing drugs to market, and the first aging...
2021-08-1839 min